USP14 promotes the malignant progression and ibrutinib resistance of mantle cell lymphoma by stabilizing XPO1

Background: Mantle cell lymphoma (MCL) is a heterogeneous disease belonging to non-Hodgkin's lymphoma. In recent years, the morbidity rate of MCL is ascending, and the prognosis remains unfavorable. Ubiquitin-specific proteases14 (USP14) has been evidenced to be engaged in the process of malign...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Ye, Lu, Peng, Jin, Shenhe, Zhang, Jin, Zhou, Yan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2023
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10110470/
https://www.ncbi.nlm.nih.gov/pubmed/37082728
http://dx.doi.org/10.7150/ijms.80467

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10110470/
https://www.ncbi.nlm.nih.gov/pubmed/37082728
http://dx.doi.org/10.7150/ijms.80467

Ejemplares similares